Page last updated: 2024-09-03

tris(2-carboxyethyl)phosphine and triiodothyronine

tris(2-carboxyethyl)phosphine has been researched along with triiodothyronine in 1 studies

Compound Research Comparison

Studies
(tris(2-carboxyethyl)phosphine)
Trials
(tris(2-carboxyethyl)phosphine)
Recent Studies (post-2010)
(tris(2-carboxyethyl)phosphine)
Studies
(triiodothyronine)
Trials
(triiodothyronine)
Recent Studies (post-2010) (triiodothyronine)
266114526,2478613,473

Protein Interaction Comparison

ProteinTaxonomytris(2-carboxyethyl)phosphine (IC50)triiodothyronine (IC50)
Thyroid hormone receptor alphaHomo sapiens (human)0.0006
Thyroid hormone receptor betaHomo sapiens (human)0.0006
Proliferating cell nuclear antigenHomo sapiens (human)3.6
Thyroid hormone receptor betaRattus norvegicus (Norway rat)0.0031
Adenosine receptor A1Homo sapiens (human)0.4109

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guan, X; Jiang, G; Li, A; Li, Y; Liu, M; Meng, L; Zhang, G; Zhang, Q; Zhu, J1

Other Studies

1 other study(ies) available for tris(2-carboxyethyl)phosphine and triiodothyronine

ArticleYear
Exposure to Novel Brominated Flame Retardants and Organophosphate Esters and Associations with Thyroid Cancer Risk: A Case-Control Study in Eastern China.
    Environmental science & technology, 2022, 12-20, Volume: 56, Issue:24

    Topics: Case-Control Studies; China; Environmental Monitoring; Esters; Female; Flame Retardants; Humans; Male; Organophosphates; Phosphates; Thyroid Neoplasms; Thyroxine; Triiodothyronine

2022